List of Sessions - ACP CME 175

Speaker: Heather C. Yun, MC USAF, FACP

• What are risk factors for the emergence of zoonotic infections into human populations?
• What are the 4 to 5 emerging infections that have been most clinically relevant in the past 12 to 18 months, including their epidemiology, manifestations, diagnosis, and management?
• What can a general internal medicine physician do to stay aware of emerging trends and help prevent emerging infections?

Moderator: David J. Pugach, JD
Panelists: George Lyons, Jr., JD-MBA • Brian E. Outland, PhD

• Attend an extremely timely and in-depth presentation on hot public policy issues that are of most concern to internal medicine.
• Learn what ACP is doing about these issues and how members can become involved.
• Receive an opportunity for direct questioning of ACP Washington staff.

Director: Pelin Batur, MD, MSCP, FACP

• Review newest contraceptives, and how they compare to the older products.
• Understand the rationale for choosing between agents.
• Discuss medical scenarios that would dictate use of one contraceptive over another.

Speaker: Steven R. Goldstein, MD, MSCP, CDD, FACOG, FRCOG(H)

• What history, physical exam, and laboratory tests are appropriate to evaluate amenorrhea?
• What history, physical exam, and laboratory tests are appropriate to evaluate abnormal uterine bleeding?
• What are appropriate roles and sequence of ultrasound and endometrial biopsy in evaluating abnormal uterine bleeding?

Speaker: David D. Berg, MD, MPH

• What is the initial evaluation of acute coronary syndrome (ACS), and which diagnostic tests (imaging, biomarkers, and noninvasive and invasive testing) should be performed?
• What is guideline-directed medical therapy for ACS?
• When are coronary angiography and revascularization indicated? Which stent, which medications, and for how long?

Speaker: Michael J. Connor, Jr., MD

• What is the definition of acute kidney injury (AKI), and what are the most common causes of AKI in hospitalized patients?
• What is the approach to diagnosing and managing AKI in hospitalized patients? Diuretic use in AKI? Timing of dialysis initiation in AKI?
• When is it safe to discharge a patient with new AKI?

Speaker: Charles Reznikoff, MD, FACP, FASAM

• What are brief, practical screening tools for treating patients with substance use disorders that can be used in a busy primary care practice?
• When can an internal medicine physician initiate buprenorphine, and when should a patient be seen by an addiction specialist?
• What is the latest on safe injection sites in the United States?
• What new treatments are available for patients with stimulant use disorders?
• What pharmacotherapy can a primary care physician initiate for outpatient treatment of alcohol use disorder?

Moderator: Alicia I. Arbaje, MD, MPH, PhD, FACP
Panelists: Melanie Jay, MD, MS • Ana Maria Lopez, MD, MPH, MACP, FRCP (London)

• What actions can be taken to advance equity through obesity care education, focusing on cultivating both clinical expertise and empathetic patient interactions?
• What initiatives can be undertaken to promote interdisciplinary collaboration in obesity care among various medical subspecialties, ensuring a comprehensive and patient-centered approach?
• What practical measures can healthcare providers and policy makers implement to combat bias, stigma, and misinformation surrounding obesity, thereby promoting equitable and respectful treatment for all individuals?
• What ACP resources can help you effectively address obesity with your patients?

Moderator: Christina C. Wee, MD, MPH, FACP
Panelist: Stephanie Chang, MD, Member

• Become aware of recent studies with implications for internal medicine practice, research, and education.

Speaker: Paul Pottinger, MD, FACP, FIDSA

• What are the major challenges in antibiotic resistance facing internal medicine physicians today?
• How does one best manage MRSA infections, in particular contrasting bacteremia with localized infections?
• How does one best manage infections with resistant Enterobacteriales, with a focus on AmpC, ESBL, and CRE management?
• How does one best manage infections with Pseudomonas and other multidrug-resistant environmental organisms?

Speaker: Kelley Branch, MD, MSc

• What are the recommendations for the use of antiplatelet therapy for primary and secondary prevention in coronary artery disease?
• When should dual antiplatelet therapy be discontinued, and when can it be interrupted?
• What are the anticoagulation strategies for stroke prevention in valvular versus nonvalvular atrial fibrillation?
• When should I stop aspirin if a direct oral anticoagulant (DOAC) is being started?

Moderator: Deepti Pandita, MD, FACP, FAMIA
Panelists: Jonathan H. Chen, MD, PhD, Member • Ivana Jankovic, MD

• Learn how augmented intelligence (AI) and machine learning (ML) technologies, including large language models and generative AI, are used in health care to manage high-volume data sets, as well as the tools and technologies with embedded AI and ML functionality.
• Understand what predictive models are used for, how the models are developed, and how they relate to clinical guidelines to maximize AI/ML utility in a practice setting.
• Identify the risks and benefits to these technologies and what questions to ask when you or your practice are considering integrating these technologies.

Speaker: Brian E. Lacy, MD, PhD, FACG

• What are the most common causes of chronic diarrhea in resource-rich countries?
• What is the optimal initial work-up for patients with chronic watery diarrhea?
• What is the role for fecal calprotectin, fecal lactoferrin, erythrocyte sedimentation rate (ESR), and serum C-reactive protein (CRP) in the work-up of chronic diarrhea?
• When should patients with chronic diarrhea be referred to a gastroenterologist?

Moderator: Kristen R. Toups, MD, MPH, FACP
Panelists: Heather Hofmann, MD, FACP • Adam Rodman, MD, MPH, FACP

• Identify three ways that the modern Subjective, Objective, Assessment and Plan (SOAP) note is problematic in health care communication.
• Should the Review of Symptoms (ROS) still be part of the notes?
• List the benefits and risks of using the modern SOAP note for diagnostic reasoning.
• Describe one way to “restore the story.”

Speaker: Fred R. Buckhold, III, MD, FACP

• How did we used to use aspirin for primary prevention of cardiovascular and cerebrovascular events, and what should we be doing now?
• How does aspirin affect colorectal cancer as well as overall cancer rates and mortality?
• Aspirin in older adults: Who should start it, who should continue it, and when if ever should it be discontinued if it was already started?

Speaker: David J. Callans, MD

• What are primary points of managing thromboembolic risk in patients with atrial fibrillation?
• What are current pharmacologic therapeutic guidelines for atrial fibrillation?
• What parameters are important to decide on for catheter ablation?
• When should I refer new atrial fibrillation to cardiology?

Speaker: Kimberly A. Lyn Shue, MD

• What symptoms and presentation of back pain might indicate a serious underlying condition?
• When is imaging necessary and evidence based?
• What are the evidence-based nonpharmacologic interventions for back pain?
• What medications come after nonsteroidal anti-inflammatory drugs (NSAIDs)?
• When is surgery or more advanced treatment indicated?

Moderator: Carrie A. Horwitch, MD, MPH, MACP
Panelist: Leslie-Ann Williams, MD, FACP

• Define patient-centered care and key goals for achievement.
• Discuss why and how to incorporate the patient voice into the electronic health record (EHR) and in the office/hospital visit.
• Discuss racial, economic, and other bias and how a patient centered approach can reduce these biases.
• Identify resources and tools to improve the patient-centered care we provide.

Speaker: Erin F. Cobain, MD

• What are the common questions of a patient with a concerning mammogram or palpable mass?
• How do you counsel a patient after their positive biopsy regarding the roles that surgery, radiation, and medical therapy may play?
• What are the targets and therapeutics of breast cancer (e.g., hormone receptor; HER2; and roles of hormonal therapy, chemotherapy, and immunotherapy)?
• When should I refer a patient with personal or family history of breast cancer to a specialized risk assessment clinic to consider high risk breast cancer screening and/or genetic testing?

Speaker: Meena Seshamani, MD, PhD

• How do quality measures translate into quality outcomes?
• How can Medicare improve quality without increasing administrative burden?
• How do we improve access to high-quality, equitable care to patients without undue cost and burden to health systems and physicians?

Speaker: Frank C. Sciurba, MD, FCCP

• What are the risk factors associated with chronic obstructive pulmonary disease (COPD) exacerbation?
• Are there different mechanisms and subtypes of COPD exacerbations?
• What are the best approaches for long-term control and prevention of COPD exacerbations?

Speaker: Roy M. Gulick, MD, MPH

• What are the most up-to-date treatment recommendations for both outpatients and inpatients with COVID-19?
• How does one diagnose long COVID-19, and what have we learned about its prognosis and treatment?
• What is the current state of COVID-19 prevention efforts, including vaccinations and treatments?

Speaker: Ellie Grossman, MD, MPH

• Which conditions are most appropriate for treatment with cannabinoids based on the evidence?
• What are the side effects and drug interactions to be aware of?
• What is the current state of the law regarding cannabinoids for clinical care?
• I’m interested in learning how to certify! On a practical level, how does this work?

Speaker: Samuel Brondfield, MD, MAEd

• What are the classic carcinoma of unknown primary (CUP) presentations indicating specific therapy (e.g., axillary node adeno, cervical node squamous)?
• How extensive a work-up is justified for determining a primary site (e.g., PET and endoscopy)?
• What is the role of the pathology report in suggesting an origin of cancer or target of therapy?
• Can molecular diagnostics inform personalized therapy?

Speaker: Anita Deswal, MD, MBBS, MPH

• What is cardio-oncology, and why should the internal medicine physician know about it?
• What are the cardiovascular (CV) risks and associated CV manifestations of oncologic therapies?
• What pharmacologic and non-pharmacologic management strategies can be implemented to reduce CV risk in these patients?
• How should the primary care physician manage cardiac health of those who survive cancer?

Speaker: Margaret E. Long, MD

• At what ages should cervical cancer screening begin and end?
• How should clinicians follow up on cervical cancer screening results of \"ASCUS\" and \"HPV positive\"?
• How does the choice of screening test (HPV, cytology, and co-testing) vary according to age?

Director: Birju B. Patel, MD, FACP, AGSF

• Understand factors that lead to polypharmacy and tools to reduce polypharmacy.
• Be able to appropriately dose medications based on age related physiological changes.
• Recognize potentially inappropriate medications for older adults.
• Recognize important lesser known drug-drug and drug-disease interactions.

Speaker: Anuj Gupta, MD, FACC, FSCAI

• Which patients should I suspect of having peripheral artery disease (PAD)?
• How do I approach the diagnosis of PAD?
• How do I manage cardiovascular risk in patients with PAD?

Speaker: John M. Kelso, MD

• What are the clinical features of chronic urticaria and angioedema?
• What are the types of angioedema, and how are they triggered?
• How is chronic urticaria diagnosed and managed?
• How are both acute and chronic episodes of angioedema managed?

Moderator: John B. Bundrick, MD, MACP
Panelists: Michael W. Cullen, MD • Megan Dulohery Scrodin, MD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of \"pearls\" that can be applied to patient care.

Moderator: John B. Bundrick, MD, MACP
Panelists: Xiao Jing (Iris) Wang, MD • Rahma Warsame, MD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of \"pearls\" that can be applied to patient care.

Moderator: John B. Bundrick, MD, MACP
Panelist: Steven L. Cohn, MD, MACP, SFHM, FRCP

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of \"pearls\" that can be applied to patient care.

Moderator: Jason M. Goldman, MD, FACP
Panelists: Bennett Caughey, MD • Erin F. Cobain, MD • Sherronda Moore Henderson, MD, FACP

• Segment A: Breast Cancer What about screening in higher-risk patients—and who are those patients? When should screening stop, and why? What about screening in higher-risk patients – and who are those patients? Is there a role for breast MRI?
• Segment B: Prostate Cancer What are the current screening guidelines, and what’s the evidence? When should screening stop, and why? What about screening in higher-risk patients—and who are those patients? Is there anything better than PSA?
• Segment C: Colon Cancer What are the current screening guidelines, and what is the evidence? When should screening stop, and why? What about screening in higher-risk patients—and who are those patients? How good are modalities other than colonoscopy?

Moderator: Todd Simon, MD, MSEd, FACP
Panelists: Manisha G. Holmes, MD, FAES • Elizabeth Loder, MD, MPH • Sara K. Rostanski, MD

• Segment A: Headache What “red flags” should prompt imaging and possibly referral to neurology or the emergency room? Tension headache or migraine: How to tell the difference, and how will it affect treatment? What new treatments are available for headaches?
• Segment B: Seizures What do primary care doctors need to know about follow-up of patients on antiepileptic medications? When does a patient with “stable” epilepsy need neurology follow-up? When can you consider reducing or stopping antiepileptic medication? What are the guidelines about driving for patients with epilepsy?
• Segment C: Transient Ischemic Attack (TIA) How should a patient with an apparent TIA be evaluated? What can be done as an outpatient? What are the best practice guidelines for secondary stroke prevention after TIA? What is the prognosis after TIA? How do you counsel patients?

Speaker: Ari M. Grinspan, MD

• What specific tests and diagnostic algorithms should be used to diagnose Clostridioides (formerly Clostridium) difficile infection?
• How are initial episodes of C difficile infection managed in non-severe, severe, and fulminant cases?
• How is recurrent C difficile infection managed, and when should fecal microbiota transplantation be considered?
• What novel therapeutics are on the horizon for future therapies?

Speaker: Christin DeStefano, MD, FACP

• How is bleeding and clotting risk assessed in cirrhosis?
• When can/should portal vein thrombosis be anticoagulated?
• How can liver disease–associated bleeding be treated?
• When can a patient with an elevated INR or low platelets be anticoagulated?

Speaker: Bennett Caughey, MD

• What are the common questions of a patient recently diagnosed with colon cancer?
• What are the roles of surgery, radiation therapy, and chemotherapy in the treatment of colon cancer?
• What are the new and emerging treatments for colon cancer?

Speaker: Victoria E. Burke, MD, FACP

• Urinary tract infections: Which patients need a urinalysis? What about a urine culture? What findings actually warrant treatment, and what's new in picking the best antibiotics?
• Skin and soft tissue infections: Can any abscesses be treated with just drainage, and which ones require antibiotics? Who should I assume might have MRSA? And which patients with cellulitis need to go to the hospital?
• Lower respiratory tract infections: How do I \"confirm\" a bacterial pneumonia (does everyone need a chest x-ray)? And if I've decided to start antibiotics, how do I tailor the choice? Who can I safely treat in the office, and who should I be sending to the ER for further evaluation?

Moderator: Dawn E. DeWitt, MD, MSc, MACP, FRACP, FRCP-London
Panelists: Marianne Parshley, MD, FACP • Grant M. Smith, MD

• Define communities of practice and their value and variations of focus (area of interest) in the context of the physicians and health care professional teams
• Give examples of how communities of practice can support physician identity formation.
• Discuss the evidence for, and range of, communities of practice.
• Brainstorm how participants can use communities of practice in their own context to promote lifelong learning and professional fulfillment.

Speaker: Astrid Pujari, MD

• For which medical conditions has complementary and alternative medicine (CAM) been found to be safe and effective? What are the data?
• What are the potential harms of commonly used CAM modalities?
• When can you recommend acupuncture or hypnosis? How do patients access these modalities?

Co-Moderators: Geno J. Merli, MD, MACP, FHM, FSVM • Howard Weitz, MD, MACP, FRCP (London), FACC

• Join the Annals Consult Guys as they address a variety of clinical issues while using humor to deliver educational pearls related to the practice of internal medicine.

Speaker: Sharon K. Inouye, MD, MPH, MACP

• What are the most common causes and presentations of delirium in the hospital setting?
• What assessment methods and tools are available for diagnosing delirium?
• What should a hospitalist know about the management and prevention of delirium?

Speaker: Patrick Hemming, MD

• What are practical tools that internal medicine physicians can use to screen for, diagnose, and quantify depression and anxiety?
• Are there apps that have evidence to support their efficacy in helping patients self-manage their depression and anxiety?
• What treatment regimens for depression and anxiety should internal medicine physicians be able to initiate and titrate?
• When is it time for a referral to psychiatry?

Speaker: Adam D. Lipworth, MD

• What are some of the most common examples of dermatologic conditions encountered in hospitalized patients?
• How can one distinguish between cellulitis and other mimics?
• What are the \"do-not-miss\" dermatologic diagnoses in hospitalized patients? And how do these look in patients with darker skin?

Speaker: Roy Colven, MD

• Which common rashes should I be able to recognize and manage?
• Which lesions should I never miss, and which require referral and/or biopsy?
• Which topical treatments should I be comfortable prescribing, and which should I avoid?

Speaker: Atul Deodhar, MD

• What is the differential diagnosis of 'primary low back pain'?
• What are the important clinical considerations in a patient with a swollen knee?
• What pharmacologic and nonpharmacologic interventions are most effective and safe in the management of osteoarthritis?

Speaker: Michelle McMacken, MD, FACP, DipABLM

• What is a Mediterranean diet, and what is the evidence for its health benefits?
• What is a keto diet, who might it benefit, and what are its drawbacks?
• Is there value in intermittent fasting?
• Who should be on a DASH diet these days?
• For patients interested in a plant-based diet, what are the health benefits and how can patients get started?

Speaker: Xiao Jing (Iris) Wang, MD

• Which patients with symptoms suggestive of irritable bowel syndrome (IBS) or functional dyspepsia should undergo endoscopy?
• What is the optimal medication trial sequence for IBS and functional dyspepsia?
• What are the important differences between cannabinoid hyperemesis syndrome and cyclic vomiting syndrome?

Speaker: Kaveh Sharzehi, MD, MS

• What is the optimal management of diverticulitis? Who needs antibiotics? Who needs surgery?
• Which patients with diverticulitis need a follow-up colonoscopy?
• Which patients with appendicitis can be safely managed without surgery?

Speaker: Randy Cron, MD, PhD

• Is cytokine storm a new description of an old disease?
• How do the inflammatory syndromes of hemophagocytic lymphohistiocytosis (HLH), macrophage activation syndrome (MAS), and Castleman disease relate?
• Can the redundancy and feedback of the inflammatory response be modulated for clinical benefit?

Speaker: Rachel Simon, MD

• What exactly are e-cigarettes?
• How do e-cigarettes impact smoking rates and cessation success?
• What are the health effects of e-cigarettes compared with combustible cigarettes?
• How do I help patients quit using e-cigarettes—or should I, for that matter?

Speaker: George Bakris, MD

• What is chronic kidney disease (CKD), and who is at risk?
• What is the appropriate screening for patients at risk for CKD?
• What is the appropriate treatment for patients with diabetic and nondiabetic kidney disease?
• When should you refer a patient with CKD to nephrology?

Moderator: Sarah G. Candler, MD, MPH, FACP
Panelists: Ali M. Khan, MD, MPP, FACP • Ryan D. Mire, MD, MACP

• Define models of practice: employed vs. single private practice vs. single specialty group practice.
• Discuss the considerations to weigh when deciding to open or join a private practice.
• Identify strategies for navigating from employed role to private practice.

Moderator: Jan K. Carney, MD, MPH, MACP
Panelists: Amy K. Holbrook, MD, FACP • Erik Wallace, MD, MACP

• What ethical challenges do dis- and misinformation pose for physicians?
• What issues do they raise for academic discourse, especially when clinical evidence is lacking or still evolving as was the case, for example, in the COVID-19 pandemic?
• What are ethical best practices in talking to patients when disinformation is raised?

Speaker: Julia McNabb-Baltar, MD, MPH

• How is acute pancreatitis diagnosed?
• What is the appropriate management of acute pancreatitis in hospitalized patients?
• When are advanced diagnostics, including endoscopy, necessary?
• How are pancreatitis complications best managed?

Speaker: Orson W. Moe, MD

• What are the risk factors associated with nephrolithiasis?
• How should a person with recurrent stone disease be evaluated?
• What is the most appropriate dietary, pharmacologic, and surgical treatment for a patient with kidney stones?

Speaker: Neel Chokshi, MD, MBA

• Which patients need to be screened for cardiovascular disease before initiating an exercise regimen, and how should they be screened?
• Which athletes should be screened for cardiovascular disease, and how should they be screened?
• What cardiovascular conditions preclude participation in high-intensity exercise?
• If a patient has known cardiovascular disease, when can they exercise?

Moderator: Nita W. Walker, MD, FACP
Panelists: Umar Bowers, MD • Fabrizia Faustinella, MD, PhD, FACP

• Understand the intersection of health equity and the internal medicine profession.
• Highlight internal medicine physicians who are redefining our role in impacting health equity.
• Learn tools and opportunities at the individual physician level.

Speaker: Jamar Slocum, MD, Member

• How can internal medicine physicians promote equity and reduce bias in obesity management? Why is this our work?
• What is ACP doing to prevent firearm injury? Why is this our work?
• How and why are we expanding our lane at ACP?

Speaker: Elliot Tapper, MD

• What is the optimal initial and secondary work-up for patients with mild to moderately elevated aminotransferases?
• What are the indications for liver imaging/elastography in patients with undiagnosed or undifferentiated liver pathology, and how does one choose between imaging modalities?
• What are the criteria for diagnosis of nonalcoholic fatty liver disease?
• What treatment options should we recommend for patients with nonalcoholic fatty liver disease?

Speaker: Zahir Kanjee, MD, MPH, FACP

• What are possible etiologies of a new acute murmur found during hospitalization?
• What can I do to differentiate and better detect murmurs at the bedside?
• Which new murmurs do and don't require further work-up in the hospital? And what should the work-up be?

Moderator: Christine Laine, MD, MPH, FACP
Panelists: Carolyn J. Crandall, MD, MS, MACP • Sameer S. Kadri-Rodriguez, MD, MS, Member • Nisa M. Maruthur, MD, MHS, FACP

• Authors of three selected articles to be published during the Internal Medicine Meeting will present a 10-minute overview of their article.

Speaker: Peter J. Kahrilas, MD

• What are the most important side effects of proton-pump inhibitors (PPIs) that internal medicine physicians should be aware of, and how do these side effects compare with those of histamine-2 blockers?
• Which patients should not be taken off of PPIs?
• How do we minimize symptoms as we discontinue PPI therapy in appropriate patients?

Speaker: Jason M. Goldman, MD, FACP

• What are the common genetic cancer syndromes internal medicine physicians should be aware of?
• Who should be tested for these syndromes, and what tests should be used?
• What is the best management of patients with pathogenic mutations when referring to a geneticist is not an option?

Speaker: Brendan Antiochos, MD

• What are the clinical features of giant cell arteritis?
• What are the most useful diagnostic studies to consider in giant cell arteritis?
• What pharmacologic interventions are most effective in managing giant cell arteritis?

Speaker: Stephanie J. Nahas, MD, MSEd

• When do you admit a patient presenting with headache?
• What are common causes of new headache in hospitalized patients, and how should it be worked up?
• How should a headache after a fall in the hospital be managed?
• What common inpatient medications can cause new-onset headache?

Speaker: Biykem Bozkurt, MD, PhD, FACC, FAHA

• What are the initial steps in the diagnosis and management of heart failure with reduced ejection fraction?
• What are the latest therapeutic strategies for outpatient management of heart failure with reduced ejection fraction?
• When is palliative care appropriate?

Speaker: Nancy K. Sweitzer, MD, PhD

• What are the new guidelines for heart failure with reduced and preserved ejection fraction?
• Which diuretics should be used, how much, and how fast?
• What are the new therapies and approaches that will impact initial hospitalization and rehospitalization?
• How can clinicians identify advanced heart failure, and what therapeutic implications does this have?

Moderator: Richard M. Wardrop, III, MD, PhD, FACP, FAAP, FHM
Panelists: Eladio Pereira, MD, MACP • Ankita Sagar, MD, MPH, FACP

• Understand how licensing and credentialing processes deter physicians and trainees from seeking timely and appropriate mental health care.
• Identify stigmatizing questions related to mental health history asked on state licensing, hospital, and insurance program credentialing applications.
• Explore best practices in use of nonstigmatizing language by medical boards and credentialing bodies.
• Utilize the ACP toolkit on removing credentialing and licensing barriers to mental health to act at a local, state, and national level to eliminate stigmatizing language on applications.

Speaker: Joshua Liao, MD, MSc, FACP

• What are the commonly encountered pitfalls of unnecessary testing and medication prescribing?
• How does one achieve value-based care during hospitalization?

Speaker: Bruce Leff, MD, MACP

• What is the Hospital at Home model, and how is it implemented?
• How is Hospital at Home financed in light of various care models and CMS regulations?
• What are generalizable successful clinical models of Hospital at Home?

Moderator: Kenneth Prager, MD, FACP
Panelist: Kyle E. Karches, MD, PhD, Member

• What are the emerging medical ethics and professionalism issues for internal medicine physicians today?
• How do ethics issues affect patient care?
• What should clinicians consider and how should interests be balanced when ethical challenges arise?

Moderator: Jitendra Barmecha, MD, MPH, FACP, SFHM
Panelists: Kari Nadeau, MD • Heidi L. Twedt, MD, FACP, FAMIA

• Be exposed to current hot topics in medical informatics.
• Interact with faculty to learn how these new technologies and concepts may affect their practices.
• Hot Topic #1: Cures Act and Information Blocking: What Internal Medicine Physicians Need to Know
• Hot Topic #2: Climate Change and Informatics
• Become familiar with ACP’s digital health resources.

Speaker: Stephen M. Pastores, MD, MACP, FCCP, FCCM

• How can practicing physicians align with national and local guidelines to treat sepsis and septic shock?
• What are the latest hot topics regarding sepsis assessment stratification and treatment during hospitalization?
• What are tips for implementation of sepsis bundles for early sepsis treatment?

Speaker: Khalid Ismail, MD, MB, ChB

• What should the primary care physician know about in-laboratory and at-home sleep apnea testing?
• What new devices are available to treat sleep apnea?
• What are the preoperative and postoperative management considerations for patients with sleep apnea?

Moderator: Ryan Crowley
Panelists: Elizabeth A. Cerceo, MD, FACP, FHM • Caren G. Solomon, MD, MPH

• How does the health care system contribute to climate change?
• What can physicians and other stakeholders do to mitigate and adapt to climate change?
• How do zoning, land use, financial lending, and other policy decisions affect environmental factors in marginalized communities?
• How can policymakers ensure that all communities—including people of color, people with low income, and marginalized populations—deserve to live, work, learn, and play in a safe, healthy environment?
• How can physicians collaborate with public health departments, regulators, and other stakeholders to address environmental health risks in their community?

Moderator: Susan Thompson Hingle, MD, MACP, FRCP, FAMWA
Panelists: Bisi Alli, DO, MS, FACP, DipABLM, LEAN Six Sigma Black Belt • Jabraan S. Pasha, MD, FACP

• Identify tools to help create a culture of belonging from where you are.
• Share and learn from examples of specific belonging interventions that helped organizations flourish.
• Identify at least three actionable steps to implement to support greater belonging in your practice or organization.

Moderator: Gillian Naro, MD, MEd, Member
Panelists: Ashley M. McMullen, MD • Gordon D. Schiff, MD, Member

• Recognize the variety of systems and structures that allow physicians to humanize their patients.
• Learn the value of medical humanity and empathy in advancing inclusivity and antiracism.
• Learn the value of being present and witnessing suffering as a physician.
• Recognize the healthy and unhealthy, and conscious and unconscious, coping mechanisms physicians use to process events affecting humanism in their professional and personal lives, as introduced in ACP's Physicians Well-being and Professional Fulfillment resources.
• Develop techniques to debrief with your colleagues following a challenging case.

Speaker: Mark A. Supiano, MD, AGSF

• What level of blood pressure control has the greatest efficacy and safety for preventing atherosclerotic cardiovascular disease (ASCVD) and to promote brain health in older adults, especially those older than 75 years?
• What needs to be incorporated into accurate blood pressure measurement in older adults?
• What are the benefits and risks of using lower doses of multiple medications over maxing out doses of single agents?
• How can clinicians identify and communicate with older patients who may benefit from lower blood pressure treatment goals?

Speaker: Robert H. Hopkins, Jr., MD, MACP

• What recent changes have been made to the adult vaccination schedule?
• What are the best practices for vaccine administration, including issues of co-administration, storage and handling, and setting up a vaccine program?
• What are the different vaccine technologies, and how do they work? How do newer platforms impact the development of vaccines, and what other diseases are being considered for treatment?

Speaker: Ebrahim Barkoudah, MD, MPH, FACP, SFHM

• What is the difference between Merit-Based Incentive Payment Systems (MIPS) and Alternative Payment Models (APMs) and their impacts on hospital medicine?
• How vital are documentation integrity and appropriate billing for hospital medicine? What are the dos and don’ts of documentation in relation to billing and compliance?
• What are the new CMS rules about medical students and advanced practice providers (APPs) visits and billing during hospitalization? How can the recent CMS rulings be successfully implemented?

Speaker: Timothy Anderson, MD

• What are the current goals for blood pressure management during hospitalization?
• When should the hospitalist consider intensification of an outpatient blood pressure regimen? How does the presence or absence of end-organ damage affect this decision?
• Which medications are considered safest to initiate or titrate for blood pressure management during hospitalization and at the time of care transition? Which inpatient regimens are unlikely to work upon discharge?

Speaker: Yvette M. Cua, MD, Member

• Learn what's new in inpatient coding and how to recognize when to use different inpatient codes.
• Understand time-based billing, critical care codes, observation codes, advance care planning, and other inpatient situations.
• Recognize the difference between face-to-face time and unit/floor time.
• Learn how to bill correctly to avoid payment delays.

Speaker: Guillermo Umpierrez, MD, MACP

• What is the standard of care for managing diabetes in a hospitalized patient?
• How should new classes of diabetes medications be managed in the hospital?
• When do you change or add new medications during a hospitalization? How should the management incorporate high-value care principles around diabetes management during the hospitalization?
• How do you manage insulin and inpatient glycemic goals?

Speaker: Ugochi Ohuabunwa, MD, IMCP, Member

• What does an inpatient geriatric assessment look like during hospitalization?
• How does one assess frailty and functionality status in the hospital?
• How can hospitalists prepare for the postdischarge transition of care?
• When should hospitalists initiate \"Goals of Care\" conversations?
• When is it appropriate to consult geriatrics on a hospitalized patient?

Speaker: Jay Luther, MD

• What is the optimal management for cirrhosis-related upper GI hemorrhage?
• What are common pitfalls in the management of hepatic encephalopathy, ascites, hepatorenal syndrome, and cirrhosis-related coagulopathy?
• Which patients with cirrhosis should be considered for liver transplant?

Speaker: Daniel D. Dressler, MD, MSc, FACP, MHM

• Which patients presenting to the ER with syncope require hospitalization, and who can be worked up in the outpatient setting?
• What is the appropriate work-up for a patient admitted for syncope, and which symptoms prompt specific diagnostic tests?
• What is the approach to evaluation and management of syncope that newly occurs during hospitalization, and what are some of the most common causes?

Speaker: Sejal B. Shah, MD

• What are the most common acute psychiatric diagnoses encountered on the inpatient medical service?
• How does one best manage hospitalized patients with psychiatric dual diagnosis?
• What is the best way to manage a patient with suicidal ideation during hospitalization?
• How can a hospitalist ensure safe transition and placement at discharge for these patients?

Moderator: Ross W. Hilliard, MD, FACP
Panelists: Arlene E. Chung, MD, MHA, MMCi, FAMIA • Eric GR Kim, MD, PhD

• Understand the current landscape of mobile health and the data available from these devices to health care systems and physicians.
• Understand the pitfalls and guardrails when considering importing mobile health data into the electronic health record (EHR) or at point of care.
• Understand how to set up patient expectations on how their care teams may or may not be able to use their mobile health data.
• Understand the requirements and technical needs of introducing mobile health data into the EHR.

Speaker: Alan N. Brown, MD, FACP

• How do results of immunologic testing assist in establishing a diagnosis?
• What rheumatologic tests are useful to measure disease activity and assist in ongoing management?
• Which rheumatologic and immunologic tests are associated with specific disease states?

Speaker: Kevin C. Wilson, MD

• What are the criteria and tests for diagnosing interstitial lung disease (ILD)?
• What therapies are available, including medications, oxygen, pulmonary rehabilitation, and transplant?
• When should pulmonary be consulted for assistance with diagnosis and management?
• How do you best address end-of-life discussions and symptomatic management in these patients?
• When should interstitial lung disease be suspected?

Speaker: Adam C. Schaffer, MD, MPH

• What are the elements of medical malpractice?
• What are the literature updates regarding legal liability for hospital medicine compared with other specialties?
• What aspects of medical practice may represent elevated liability risk that physicians should be aware of?
• What are some ways physicians can reduce their risk of facing a medical malpractice claim?

Director: Lisa M. Filippone, MD

• Identification of life threatening and subtle ECG findings encountered in an office practice.
• Identification of subtle ECG finding associated common clinical conditions.
• Review of ECG findings of common clinical entities.

Speaker: Neha Pathak, MD, FACP, DipABLM

• What is Lifestyle Medicine, and why is it important?
• How do I realistically help patients incorporate a healthy eating pattern and physical activity into their lives?
• What are practical suggestions for stress management, and what are the health benefits for stress reduction?
• Should I be discussing loneliness with my patients, and what resources are available?
• How can I help my patient get more restorative sleep?

Moderator: Ellen J. Gelles, MD, FACP
Panelists: Rebecca G. Mishuris, MD, MS, MPH • Lisa Rotenstein, MD

• Learn how to modify electronic health record (EHR) workflows to optimize clinical and team-based collaboration in order to address patient needs.
• Determine whether there are opportunities for automation within your EHR and clinical workflows.
• Learn how to leverage the EHR to make communication and collaboration between multiple care teams more efficient and productive.

Speaker: Joan B. Ritter, MD, FACP

• What is a time-sensitive, high-yield physical examination for the foot and ankle?
• What are the major conditions of the foot and ankle that primary care physicians should know?
• When is imaging or other testing indicated?
• When should I refer foot and ankle cases to a podiatrist?

Speaker: Ralph F. Jozefowicz, MD

• Describe the purpose of performing a neurologic examination.
• Identify the seven key components of a five-minute neurologic examination.
• List the preferred order for performing a neurological examination in five minutes.

Speaker: Alayne Markland, DO

• How robust is the evidence for short- and long-term cognitive impairment with anticholinergic incontinence medications in older persons?
• What is the efficacy and safety of beta 3-agonists for urge incontinence treatment?
• How can nonpharmacologic management be implemented in clinical practice?
• What sort of procedural interventions have been shown to be effective for urinary incontinence?

Director: Carrie A. Horwitch, MD, MPH, MACP
Faculty: John-Michael Maury

• Describe core medical improv principles and their relevance to medical education and practice of medicine.
• Demonstrate and practice improvisation-based skills, and explain their application to medical communication education.
• Discuss innovative ways to bring new and fun learning techniques into your institution.

Director: Cynthia H. Chuang, MD, MSc, FACP
Faculty: Alexandra Bachorik, MD, EdM • Adelaide McClintock, MD • Mindy Sobota, MD, MS, Mphil

• Describe prevalence of early abortion and current restrictions that impede equity in access in the United States.
• List how internal medicine physicians can serve as a resource to their patients by prescribing abortion pills, referring to other trusted clinicians, and/or sharing reliable Internet resources for tele-abortion care.
• Diagnose pregnancy and offer options counseling.
• List steps to safely prescribe medication abortion, including understanding safety and effectiveness, ruling out contraindications, recognizing very rare complications, and following up to ensure abortion is complete.

Speaker: Juliana (Jewel) M. Kling, MD, MPH, FACP

• Which types of symptoms are appropriate indications for systemic and vaginal menopausal hormone therapy, and who is an appropriate candidate?
• How should physicians decide among systemic patches, gels, creams, and pill forms of menopausal hormone therapy? What about vaginal estrogen rings, inserts, and creams?
• What is bioidentical hormone therapy, and when is it appropriate?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Panelists: Carolyn J. Crandall, MD, MS, MACP • Adam J. Obley, MD, FACP

• What are the latest clinical guidelines and best practice advice/rapid practice points?
• What are the current standards of evidence-based care?
• How can I implement these guidelines into my practice?

Moderator: Alexandra M. Goodwin, MD
Panelists: Audrey Chun, MD • Caitlin Driscoll, MD, Member • Rachael Oxman, MD

• Addiction Medicine:
  • 1. When a hospitalized patient is diagnosed with alcohol use disorder (AUD), what treatments should be considered for initiation during hospitalization and discharge? In outpatient practice, is it ever appropriate to prescribe medications approved for AUD to patients with mild AUD (or risky alcohol use without AUD)?
  • 2. For patients with opioid use disorder (OUD), how do you determine if they are a good candidate for long-acting injectable buprenorphine? When should you consider low-dose buprenorphine initiation? For which patients should you recommend treatment with methadone?
• Geriatrics:
  • 1. What are the highest-yield, practical recommendations that internal medicine physicians should be giving to their community-dwelling older patients who are motivated to prevent or slow geriatric syndromes, such as frailty, falls, and memory decline?
  • 2. What is the evidence for using statins (for primary prevention), both continuing and starting new, in patients older than 80 years?
• Endocrinology:
  • 1. In hospitalized patients with uncontrolled and/or newly diagnosed type 2 diabetes, how do you select the optimal outpatient regimen? For patients discharged on a regimen of insulin, what are the evidence-based and practical safe transitions to noninsulin regimens?
  • 2. In the treatment of obesity with GLP-1 or dual GLP-1/GIP medication, when should you taper the dosage or stop the medication treatment (e.g., due to cost, achievement of weight loss goals, or concern for long-term adverse effects)? Is there any evidence or experience from shortages that should inform counseling on reduced or intermittent dosing vs. using alternative medications? How do you counsel patients on managing obesity while adjusting medications? Is there any new evidence on risks associated with long-term use of these medications and when to consider “maintenance” dosing?

Moderator: James O'Keefe, MD, FACP
Panelists: Daniel P. Hunt, MD, MHM, FACP • Megan Y. Kamath, MD • Ali Rezaie, MD, MSc, FRCPC

• Cardiology:
  • 1. Should apolipoprotein B (ApoB) replace low-density lipoprotein cholesterol (LDL-C) for diagnosis and/or monitoring of hyperlipidemia? What are the most high-value care strategies for monitoring and management of hyperlipidemia?
  • 2. What are the newest treatment approaches for diastolic heart failure, and how do we identify which patients are candidates for specific treatments?
• Gastroenterology:
  • 1. When should we consider a possible diagnosis of small intestinal bacterial overgrowth (SIBO)? Are there specific patient-level or symptom characteristics that improve diagnostic certainty, and when should confirmatory testing be sought? If testing cannot be done, what is the role for empirical treatment?
  • 2. What are the evidence-based outpatient treatments for C. difficile, and which are the preferred options? Which patients should consider secondary prophylaxis to prevent recurrence? What isolation precautions are needed for patients managed in the outpatient setting?
• Hospital Medicine:
  • 1. For management of acute pain in the hospital setting, what evidence-based practices should the hospitalist know about the use of intravenous ketamine? What are current best practices for optimizing the safe and effective use of opioid medications in the hospital, including the role of nonopioid medications and interventions for acute chronic pain management?
  • 2. What are the most evidence-based practices in the management of asymptomatic subsegmental pulmonary emboli, calf deep venous thrombosis, mesenteric thrombosis, and portal vein thrombosis? When should consultation be considered?

Moderator: Rachel P. Brook, MD, FACP
Panelists: Stephanie Faubion, MD, MBA, FACP • Narjust Florez, MD, Member • F. Eun-Hyung Lee, MD

• General Internal Medicine:
  • 1. What are the latest updates in symptomatic management of menopause? How do you counsel patients on appropriate use of diagnostic testing? When considering menopausal hormone therapy, are there indications beyond vasomotor and genitourinary symptoms?
  • 2. What is the latest evidence for cardiovascular and thrombotic events in patients receiving testosterone therapy for hypogonadism and/or erectile dysfunction?
• Oncology:
  • 1. What are the most clinically important adverse effects of newer immunotherapy treatments for malignancies that internal medicine physicians should be aware of?
  • 2. What are some high-yield examples of things internal medicine physicians should know (and tell their patients) about cancer survivorship care plans?
• Infectious Diseases/Immunology:
  • 1. For respiratory syncytial virus (RSV) vaccination, how do you counsel patients regarding the decision to vaccinate, and are there particular populations that you most strongly recommend a vaccine? How do you address requests for vaccines outside of the age-based FDA approval? Is there clinical evidence that spacing the vaccine apart from other vaccines is warranted?
  • 2. Is there evidence that treatment of COVID-19 with nirmatrelvir/ritonavir prevents long COVID? Is there any new evidence on the use of nirmatrelvir/ritonavir and symptom duration and/or severity? Is nirmatrelvir/ritonavir indicated with each infection in patients who have had COVID-19 multiple times? Is it ever indicated in patients with rebound COVID-19 infection?

Speaker: Gerald W. Smetana, MD, MACP

• Which new drugs are available that should be incorporated into your practice?
• How do new drugs compare with previously available agents in terms of efficacy and cost?
• What do you need to know about new medications in terms of side effects or drug interactions?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Panelists: Wanda Nicholson, MD, MPH, MBA • Timothy J. Wilt, MD, MPH, MACP, FRCP

• What are the latest clinical guidelines?
• What are the current standards of evidence-based care?
• How can I implement these guidelines into my practice?

Speaker: Danielle Ofri, MD, PhD, D Litt(Hon), MACP

• Explore how doctors and patients connect via stories.
• Understand how poetry can sharpen diagnostic skills.
• Reflect on the ethics of writing patients’ stories.

Speaker: Todd Simon, MD, MSEd, FACP

• When should I screen for anemia? Is there such a thing as an annual complete blood count (CBC)?
• Should I just order a thyroid stimulating hormone (TSH) and hemoglobin A1c test on all my patients?
• Who should be screened for abdominal aortic aneurysm (AAA), and who should not be?
• What is the validity and best practice for depression screening? What resources do I need?

Speaker: Nicholas S. Hill, MD, FACP

• What are the optimal oxygen level targets?
• What are the characteristics of conventional oxygen therapy, noninvasive ventilation, and high-flow nasal oxygen?
• What are the indications for high-flow nasal oxygen and noninvasive ventilation?
• What are the risks associated with noninvasive oxygenation strategies?

Speaker: David S. Seres, MD, ScM, PNS, FASPEN

• What are the appropriate screening tools and diagnostic criteria for moderate to severe malnutrition in hospitalized patients?
• What are the appropriate criteria to start parenteral nutrition? What are the common risks and complications of parenteral nutrition?
• What are some common nutrition abnormalities that hospitalists are likely to encounter and manage?
• When do patients truly need to be NPO? Are there common examples of situations when patients are kept NPO unnecessarily?

Moderator: Valerie G. Press, MD, MPH, FACP, SFHM
Panelists: Oluseyi Fayanju, MD • Allison M. Panzer, MD, MPH

• What are the criteria for diagnosing obstructive lung disease, and can it be diagnosed during an exacerbation?
• How does one determine disease severity, and which patients are at higher risk for recurrent exacerbations?
• What are the treatment approaches to managing an acute exacerbation of COPD and asthma in the hospital?
• What is the hospitalist's role in severe obstructive lung disease and end-of-life management?

Speaker: Rakesh Mehta, MD

• Which tests are required to initially characterize an anemia?
• How do you balance high-value care in test ordering with the convenience of minimizing patient travel and return visits?
• What are the clues and follow-up tests to diagnose hemolytic anemia?
• When are the CBC and clinical context enough to characterize anemia without further testing?

Speaker: John M. Kelso, MD

• Which patients are appropriate candidates for allergy testing in the primary care physician (PCP) practice?
• How is an allergy testing program established in a PCP practice?
• What diagnostic studies and concurrent laboratory testing are useful for PCP office-based allergy testing?

Lecturer: Eric J. Topol, MD, MACP

• Lecture title: How A.I. Will Change Medicine • How A.I. has the potential to transform the future of medicine. • The power of machine eyes. • How the gift of time for clinicians can be restored. • Gearing up for hospital-at-home and other multimodal AI opportunities.

Speaker: Stephanie Jones Marioneaux, MD

• The red eye and when should patients be referred to the ophthalmologist?
• What are the common ocular complaints that internal medicine physicians will address?
• How to approach ocular complaints and generate the differential diagnosis?

Speaker: Ann R. Garment, MD, FACP

• Which patients are appropriate candidates for treatment of opioid use disorder (OUD) with buprenorphine versus naltrexone in the primary care setting? And how can I be ready to offer these to my patients?
• Who is a good candidate for extended-release buprenorphine injections? What about low-dose buprenorphine dosing?
• How do I address chronic pain management in patients with OUD, and which patients with chronic pain are at risk for progression to OUD?

Moderator: Elisa Choi, MD, FACP, FIDSA
Panelists: Sarah Krug • Matthew Sakumoto, MD, FACP

• Define team-based care for telehealth-based care delivery and how this can benefit both physicians and patients.
• Learn about setting up patient expectations of care when delivering team-based telehealth, including modalities like care at home and remote patient monitoring.
• Learn about challenges and potential pitfalls in setting up team-based telehealth and how to mitigate these.

Speaker: Steven D. Curry, MD

• What is the best practice when patients present with hearing loss?
• How do I approach patients with dizziness?
• What is the appropriate management of otitis media and tympanic membrane rupture? Why are Q-tips so bad? What else should be used for cerumen?

Speaker: Jeannine Z. Engel, MD, MACP

• Learn how to use new evaluation and management (EandM) codes, as well as other new codes, and how they affect the bottom line.
• Understand how to optimize payment, code accurately and efficiently, and reduce administrative burdens and risk.
• Learn the basics of coding and documenting office visits and preventive services and how to accurately select the level of office visit service to maximize revenue and minimize audit risk.

Speaker: Anjlee Mahajan, MD

• Which patients with deep vein thrombosis (DVT) can be treated as outpatients?
• What are the barriers to outpatient care of venous thromboembolism (VTE), and how are they overcome?
• Which patients with pulmonary embolism are eligible for outpatient therapy or early hospital discharge?

Speaker: Efren C. Manjarrez, MD, FACP, SFHM

• What tests, studies, and exams are actually needed preoperatively?
• How do you manage direct oral anticoagulants in the perioperative setting as an outpatient?
• Which medications need to be stopped or changed in the perioperative period?

Speaker: Elenore Bhatraju, MD

• What are some effective communication strategies for discussing pain in hospitalized patients?
• What are the pharmacologic versus nonpharmacologic options for managing pain in the hospitalized patient?
• What strategies should be used for hospitalized patients with opioid use disorder (OUD)?

Speaker: Janet Abrahm, MD, FAAHPM

• What are the common symptoms at the end of life, and what is the management of these symptoms?
• What are the validated communication strategies to use when addressing goals of care with patients and families?
• When should I request a palliative care consult?

Speaker: Richard G. Wunderink, MD

• What risk scores help stratify level of care for hospitalized patients with pneumonia?
• What should a hospitalist know about empirical coverage for drug-resistant pathogens? When is procalcitonin useful in the clinical decision making?
• What are the differences between community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-acquired pneumonia (VAP)?
• Which diagnostic testing should be performed to identify an etiology and promote good antimicrobial stewardship?
• What are the recommended empirical treatment regimens, routes of administration, and durations of therapy for CAP, HAP, and VAP?

Moderator: David J. Pugach, JD
Panelists: Sarah G. Candler, MD, MPH, FACP • William Fox, MD, FACP

• How can policymakers foster team-based, physician-led care?
• How can policymakers facilitate the appropriate transition of care between primary and specialty care settings and ensure high-quality postdischarge care?
• How can policymakers ensure a sufficient primary care physician workforce? What are the benefits of primary care investment?

Speaker: Anuja Dokras, MD, MHCI, PhD

• How do you diagnose polycystic ovary syndrome (PCOS)?
• What are screening recommendations for patients with PCOS?
• What are the lifestyle modifications and medical therapies for PCOS?
• When should an internal medicine physician refer a patient with PCOS?

Speaker: Kristine E. Ensrud, MD, MPH, MACP

• What specific pharmacologic agents should be used to initiate osteoporosis drug treatment (ODT)?
• How long should patients receive ODT and for which patients should clinicians consider initiating drug holiday or switching to alternative agent?
• Which patients are candidates for anabolic therapy?

Moderator: Vidya Sundareshan, MD, MBBS, FACP, FIDSA
Panelists: Jason M. Goldman, MD, FACP • Saba A. Hasan, MD, MACP

• Summarize current Advisory Committee on Immunization Practices (ACIP) recommendations for adults.
• Engage patients in effective vaccine conversations.
• Identify three practical strategies to increase adult immunization rates in your practice.

Speaker: Christine Soong, MD, MSc

• When should cardiac biomarkers be used for diagnosis and prognosis during hospitalization?
• What are opportunities to reduce low-value cardiac biomarker testing during hospitalization?
• What are effective quality improvement interventions to reduce unnecessary biomarker testing among hospitalized patients?

Speaker: Kurt Pfeifer, MD, FACP

• How does one perform a cardiac risk assessment for a preoperative evaluation in the hospital?
• What is the role of functional status, biomarkers, and noninvasive testing during evaluation?
• What are the diagnostic criteria, characteristics, and predictors of myocardial injury after noncardiac surgery (MINS)?
• Which cardiac medications should be continued or paused perioperatively? What is the evidence behind these changes?

Speaker: Scott C. Litin, MD, MACP

• How do I organize a teaching presentation with special emphasis on an effective opening and a strong closing?
• What are some helpful skills for presentation techniques?
• How can I create and deliver my next presentation more effectively than I have in the past?
• How can I constructively critique presentations of others and provide helpful suggestions?

Speaker: Manish Singla, MD, FACP, USN

• What side effects of medications used to treat inflammatory bowel disease should internal medicine physicians be aware of?
• What is the optimal vaccination schedule for patients with inflammatory bowel disease on immunomodulatory therapy?
• How does health care maintenance differ for patients with inflammatory bowel disease compared with average adults (including osteoporosis, cardiovascular disease, and vaccinations)?
• What pitfalls do you see internal medicine physicians fall into when caring for patients with inflammatory bowel disease?

Speaker: Amanda Downey, MD

• What are the elements of history taking and medical screening needed to accurately identify patients with eating disorders, including anorexia nervosa, bulimia nervosa, avoidant/restrictive food intake disorder, and binge eating disorder?
• What are the misconceptions and implicit biases related to the topic of eating disorders?
• What are common medical complications and long-term health risks associated with eating disorders?
• What are the common medical interventions for patients with eating disorders, and when are referrals and additional support warranted?

Speaker: Sherronda Moore Henderson, MD, FACP

• What are the common questions of a patient recently diagnosed with prostate cancer?
• What are the relative roles of surgery, radiation, and hormonal therapy and chemotherapy in the treatment of prostate cancer?
• What are the long-term survivorship issues for people with prostate cancer?

Co-Moderators: Omar T. Atiq, MD, MACP • Dror Dicker, MD, FACP, FACP (Hon), EFIM Immediate Past President
Panelists: Eileen Barrett, MD, MPH, MACP, FAMWA, SFHM • Ricardo Gómez Huelgas, MD, PhD, FACP, FACP (Hon)

• Understand the workplace safety challenges to physicians and their teams.
• Apply principles of safety risk mitigation to protecting health professions.
• Analyze threats to patient care presenting as threats to physician wellbeing.
• Create a plan to improve physician and patient satisfaction with care.

Professors: Joerg Ermann, MD, Member • Evan L. Siegel, MD

• What are the clinical features of psoriatic arthritis and rheumatoid arthritis, and how do they differ from each other and from osteoarthritis?
• How are psoriatic arthritis and rheumatoid arthritis related to cardiovascular risk and the metabolic syndrome?
• What new treatment options have become available for psoriatic arthritis and rheumatoid arthritis, and how are these treatments managed?

Speaker: Fred Kusumoto, MD

• What are the most common electrocardiogram (ECG) abnormalities seen in an internal medicine physician's practice?
• What findings on an ECG warrant an urgent referral for acute care or a cardiology consult?
• What are hallmark findings on an ECG that suggest an underlying genetic abnormality?

Speaker: Sunil B. Kripalani, MD, MSc, FACP, SFHM

• What are the best practices for medication reconciliation upon the transition of care in terms of outcomes and patient-centered value?
• What are the tools for medication reconciliation upon transition of care?

Speaker: Greg Martin, MD, MSc

• What are the properties of the various intravenous fluids used in hospitalized patients?
• What are the goals of fluid therapy, and how does one select and dose the right type of intravenous fluid?
• What are the side effects to consider when using resuscitation fluids in hospitalized patients?

Speaker: Daniel E. Soffer, MD, FNLA

• What biomarkers and imaging modalities are used to identify patients at high risk for cardiovascular disease?
• What lipid management strategies are recommended for moderate- to high-risk patients? What do you do when initiation of treatment is a \"close call\"?
• When should a PCSK-9 inhibitor be considered? When should referral to a lipidologist be considered?
• Are statins enough?
• Why is there residual risk after intensive lipid lowering?

Speaker: Richard E. Greene, MD, MHPE, FACP

• What are the gaps between patient and clinician perceptions about how sex is discussed in clinical encounters?
• How can clinicians take an inclusive and orientation-neutral sexual history?
• What are commonly missed opportunities for engaging with patients about their sexual health?
• How can internal medicine physicians create a safe space for patients to discuss sexual satisfaction and libido in the context of a medical visit?

Speaker: Rebecca Lillis, MD

• What are the guideline-endorsed screening recommendations for sexually transmitted infections (STIs) in the United States?
• What are the most important updates for the management of common STIs, such as gonorrhea, chlamydia, M genitalium, syphilis, trichomonas, and pelvic inflammatory disease (PID)?

Speaker: Maureen M. Okam Achebe, MD

• What is the typical presentation of sickle cell disease (SCD) vaso-occlusive episode?
• Which patients experiencing a pain episode should be admitted, and how should this condition be worked up once admitted?
• Which severe complications of SCD should the hospitalist be aware of, and how are they managed?
• When should patient with SCD receive a blood transfusion?
• How can SCD complications be prevented?

Speaker: Jonathan Ripp, MD, MPH, FACP

• Identify tools to help you align organizational and clinician well-being goals regardless of your title or position.
• Share and learn from examples of specific interventions that helped organizations operationalize well-being in a meaningful way.
• Identify at least three actionable steps to implement in your practice or organization.

Speaker: Michael Emmett, MD, MACP

• How do you evaluate a patient with hyponatremia?
• How do you appropriately treat a patient with hyponatremia?
• How do you evaluate a patient with hypernatremia?
• How do you appropriately treat a patient with hypernatremia?

Speaker: Tracy Tylee, MD

• What is the evidence that treatment of subclinical hypothyroidism has beneficial outcomes?
• What is the evidence that treatment of subclinical hyperthyroidism has beneficial outcomes?
• What is the approach to selecting a treatment for subclinical hyperthyroidism?

Moderator: Craig Keenan, MD, FACP
Panelists: Stacy Higgins, MD, FACP • Donna Williams, MD, FACP

• Learn about creating a positive and educational learning environment, despite the chaotic work space and competing pressures of caring for patients in the hospital.
• Review strategies for making teaching points relevant, pithy, and memorable for learners—using teaching “scripts,” artful questioning, bedside teaching, and summary.
• Review reasons to teach at the patient bedside, as well methods for optimizing bedside teaching.
• Learn about best available practices for continuous educator self-improvement.

Speaker: Kathleen M. Finn, MD, FACP

• What elements should be required curricula for teaching during inpatient rotations?
• What are concrete tips for giving feedback on the wards and teaching at the bedside?
• What strategies can be used to improve learners' clinical reasoning and diagnostic decision-making skills? What strategies can be used to deal with uncertainty?
• What teaching resources are needed in community programs that may not have as much academic infrastructure in university settings?
• What are the educational goals for inpatient rotations for students and residents?
• How do you teach to multi-level learners?

Speaker: Bradley D. Anawalt, MD, FACP

• Who is a candidate for testosterone replacement therapy, and how do you evaluate and then monitor them?
• What different formulations of testosterone are available, how should they be used, and what are the risks and benefits of each?
• Is there a role for testosterone therapy in women, and if so, what's the harm?

Moderator: Kerry L. Reynolds, MD

• What are the most commonly encountered oncologic emergencies in hospitalized patients, and how are they diagnosed and managed?
• What are the risk factors for immune-related adverse events in patients with cancer, and how should these events be managed?

Moderator: Zoe Arvanitakis, MD, MS, EBMA
Panelists: Marie Boltz, PhD, GNP-BC, FGSA, FAAN • Nilufer Ertekin-Taner, MD, PhD, FAAN

• What is the current state of disease-modifying treatments for Alzheimer disease and other dementias?
• In addition to lifestyle and cardiac risk reduction interventions, which medications might slow the progression of cognitive decline?
• In addition to personalized behavioral approaches, which medications may help with behavioral symptoms associated with dementia?
• How can the clinician best support caregivers, and what additional resources outside of the clinical setting exist for caregivers to utilize?

Co-Moderators: Alexander D. Schafir, MD, FACP • David R. Scrase, MD, MHSA, MACP

• How does my clinical decision making compare with that of other internists?
• Can internal medicine really be this much fun, and am I allowed to laugh out loud through a whole presentation?
• Will I achieve instant fame and fortune by correctly diagnosing a case before it is presented on screen?

Speaker: Sandra Kane-Gill, PharmD, MS, FCCM, FCCP

• When is a drug-induced increase in creatinine considered kidney injury?
• Is there an increase in creatinine at which potentially nephrotoxic drugs should be decreased or discontinued?
• What should you monitor when using potentially nephrotoxic medications?
• What drugs should be avoided in patients with chronic kidney disease?

Speaker: Hasmeena Kathuria, MD, ATSF

• What is known about tobacco cessation programs?
• What behavioral changes should be adopted to decrease tobacco dependence?
• What are the optimal pharmacologic treatment options for tobacco dependence?
• What are the evidence-based strategies for a successful smoking cessation program?

Moderator: Betty Chang, MD, PhD, FACP
Panelist: Hera Maryam, MD, Resident/Fellow Member

• Understand the basics of how current practices fall short in terms of providing humane training culture and why it happens.
• Learn about resources available to prioritize resident well-being and humanity and how to incorporate them into daily practice effectively.
• Learn practical tips and examples to address trainees’ burnout and increase focus on humanity at the organizational and system levels, as outlined in the ACP Resident Well-being Learning Hub.

Speaker: Joseph K. Lim, MD

• What are the most common causes of transaminitis in a newly admitted hospitalized patient? What about in a patient who has already been hospitalized for a while?
• What are the approaches to evaluating transaminitis in the hospital?
• When should gastroenterology get involved in the care of these patients?

Speaker: Lorena Alarcon-Casas Wright, MD

• What should the internal medicine physician do prior to initiation of gender-affirming hormone therapy?
• What are the proven and potential benefits and complications of gender-affirming hormone therapy that the internal medicine physician should know?
• What preventive care should the internal medicine physician provide to the transgender patient who is on gender-affirming hormone therapy?

Speaker: Pooja Gala, MD, MSc

• What general considerations are important to address with patients before they travel, and where does one find updated advisories for travelers?
• What is appropriate malaria prevention counseling and medication prophylaxis? How does this apply to travelers with extended travel plans? What about pregnant patients? And patients receiving cardiac medications?
• Which patients should be traveling with medication for travelers’ diarrhea?
• What noninfectious disease considerations are important to address with patients before they travel?

Speaker: Timothy R. Sterling, MD, FACP

• How should latent tuberculosis diagnostics be utilized and interpreted?
• What are the preferred treatment regimens for latent tuberculosis based on the newest guidelines?
• What are the preferred treatment regimens for active tuberculosis, including novel shorter-course therapies?

Speaker: Rita R. Kalyani, MD, MHS

• What are the most cost-effective first- and second-line glucose-lowering therapies?
• What are the most important criteria for the selection of second and third adjunctive drugs?
• When should insulin therapy, including U300 glargine and U500 regular insulin, be considered?

Moderator: Eliseo Guallar, MD, DrPH, Member
Panelists: Christine Laine, MD, MPH, FACP • Christina C. Wee, MD, MPH, FACP

• Gain an understanding of basic concepts essential to the interpretation of medical research reports.
• Learn why being unfamiliar with these concepts can lead to a serious misinterpretation of clinical studies.

Speaker: Jay Khambhati, MD

• Who is a candidate for transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR)?
• What are the recommendations for monitoring and managing patients with mitral regurgitation in the outpatient setting?
• What are options for treatment in right-sided valvular disease?

Presenter: Christopher L. Knight, MD, FACP
Co-Presenter: Nikki Niewold Zarling, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Patricia Kritek, MD, EdM

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Carly E. Kelley, MD, MPH

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: John M. Inadomi, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Helen Fernandez, MD, MPH
Co-Presenter: Kinga Kiszko, DO

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Martha P. Mims, MD, PhD, Member

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Nkemdilim Mgbojikwe, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Fred A. Lopez, MD, MACP
Co-Presenter: Victoria E. Burke, MD, FACP

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Michael J. Ross, MD, FACP

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Jeremy P. Cetnar, MD, MS

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Jess Mandel, MD, MACP, ATSF

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Marcy B. Bolster, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Janet Pregler, MD, FACP
Co-Presenter: Carolyn J. Crandall, MD, MS, MACP

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Speaker: Noah Stratton, DO, FACP

• When are supplementary vitamins necessary?
• What diseases are treated or prevented by vitamin supplementation?
• What are the potential harms of vitamin supplementation?

Speaker: Sara K. Rostanski, MD

• For patients who have had an ischemic stroke, what work-up should be completed to determine the etiology and what is the appropriate regimen for secondary stroke prophylaxis?
• For patients who have had a hemorrhagic stroke, what work-up should be completed to determine the etiology and what is the appropriate regimen for secondary stroke prophylaxis?

Speaker: Stacy Street, MD, FACS, CWSP

• What are the types of wounds encountered in hospitalized patients?
• How are these common wounds staged and documented?
• What is the approach to the management of different types of skin injuries in the hospital?
• What is the role of nutrition, wound care service, and vascular consult for hospitalized patients with wounds?